Retirements and the outcomes of a handful of close races could reshape congressional committees tasked with oversight of issues important to labs.

According to the government, Tina Ball and her lab company knowingly billed North Carolina Medicaid for urine drug tests that were medically unnecessary.

NEW YORK – BioMérieux announced on Tuesday that it has obtained the CE mark for an assay to detect vitamin B12. The automated, quantitative test runs on the firm's Vidas immunoanalyzers.

The firm's analysts wrote that they see stability in Revvity's diagnostics business and growth above peers in its life sciences and reagents business.

Last week, readers were most interested in a story about Roche and BARDA teaming up to develop diagnostic tests for traumatic brain injuries.

The field's rapid advances make securing reimbursement an important area of focus, researchers in a recent commentary argued.

NowDx's First to Know Syphilis Test received FDA authorization in August, making it the first over-the-counter syphilis test to be authorized by the agency.

The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients ...

The company continues to build validation data and believes its lower cost proposition can help it gain leverage in the European market where molecular tests are not reimbursed.

The test is approved for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.